Drugs / 16055 NFL delta Gly4 trimer
16055 NFL delta Gly4 trimer
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06332339 | Mar 2024 → Nov 2026 expected | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 16055 NFL delta Gly4 trimer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06332339 ↗ |
| Modality | Protein / enzyme biologic | “16055 NFL Delta Gly4 Env Protein Trimer” NCT06332339 ↗ |